InterRNA Receives €1.3M Grant from Dutch Government | GenomeWeb

InterRNA Technologies said this week that it has received a €1.3 million ($1.8 million) grant from the Dutch government to support its development of microRNA-based treatments for melanoma.

The funding "allows us to further strengthen the [research and development] team and speed up the development of our miRNA-based therapy to treat more advanced stages of this aggressive form of cancer," InterRNA CEO Roel Schaapveld said in a statement.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: ancient Ethiopian genome indicates greater Eurasian backflow into Africa, sequencing to diagnose cutaneous T cell lymphoma, and more.

The US House of Representatives science committee has passed a bill to require NSF to ensure it only funds projects that are in the national interest.

DuPont teams with genome editing firm Caribou Biosciences for agricultural applications of the technology.

A blogger reviews her experience learning about her gut microbiome by shipping a sample to uBiome.